Abstract
A double blind, parallel group study was carried out to investigate the effect of inhaled budesonide in a moderate (200 micrograms) and a low (100 micrograms) twice daily dosage compared with the effect of placebo in 103 adults with mild symptomatic asthma. Subjects recorded peak expiratory flow (PEF), asthma symptoms, and beta 2 agonist consumption at home for a period of seven weeks (a one week run in and six weeks' treatment). Morning baseline PEF (around 80% of predicted normal) increased non-significantly to 88% with 200 micrograms budesonide daily and to 90% (p less than 0.05) with 400 micrograms, compared with 81% with placebo. Evening PEF (around 94% of predicted normal) did not change significantly with active or placebo treatment. By comparison with placebo, there was a significant decrease in nocturnal asthma symptoms and beta 2 agonist consumption. The changes during the day were less pronounced and significant only for 400 micrograms budesonide daily. No significant differences between the two active treatments were detected. It is concluded that low doses of inhaled budesonide are effective in patients with mild symptomatic asthma, particularly for night time symptoms and early morning lung function. The early introduction of inhaled corticosteroids for patients with mild asthma and night time symptoms may improve their quality of life during the night and early morning.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adelroth E., Rosenhall L., Glennow C. High dose inhaled budesonide in the treatment of severe steroid-dependent asthmatics. A two-year study. Allergy. 1985 Jan;40(1):58–64. doi: 10.1111/j.1398-9995.1985.tb04155.x. [DOI] [PubMed] [Google Scholar]
- Clark T. J. Inhaled corticosteroid therapy: a substitute for theophylline as well as prednisolone? J Allergy Clin Immunol. 1985 Aug;76(2 Pt 2):330–334. doi: 10.1016/0091-6749(85)90649-9. [DOI] [PubMed] [Google Scholar]
- Henriksen J. M., Dahl R. Effects of inhaled budesonide alone and in combination with low-dose terbutaline in children with exercise-induced asthma. Am Rev Respir Dis. 1983 Dec;128(6):993–997. doi: 10.1164/arrd.1983.128.6.993. [DOI] [PubMed] [Google Scholar]
- Henriksen J. M. Effect of inhalation of corticosteroids on exercise induced asthma: randomised double blind crossover study of budesonide in asthmatic children. Br Med J (Clin Res Ed) 1985 Jul 27;291(6490):248–249. doi: 10.1136/bmj.291.6490.248-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kraan J., Koëter G. H., vd Mark T. W., Sluiter H. J., de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol. 1985 Oct;76(4):628–636. doi: 10.1016/0091-6749(85)90786-9. [DOI] [PubMed] [Google Scholar]
- Laitinen L. A., Heino M., Laitinen A., Kava T., Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis. 1985 Apr;131(4):599–606. doi: 10.1164/arrd.1985.131.4.599. [DOI] [PubMed] [Google Scholar]
- Laursen L. C., Taudorf E., Weeke B. High-dose inhaled budesonide in treatment of severe steroid-dependent asthma. Eur J Respir Dis. 1986 Jan;68(1):19–28. [PubMed] [Google Scholar]
- Morris H. G. An update on treatment of asthma with inhaled steroids. N Engl Reg Allergy Proc. 1987 Mar-Apr;8(2):85–94. doi: 10.2500/108854187778994437. [DOI] [PubMed] [Google Scholar]
- Ryrfeldt A., Andersson P., Edsbäcker S., Tönnesson M., Davies D., Pauwels R. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis Suppl. 1982;122:86–95. [PubMed] [Google Scholar]
- Tivenius L., Kiviloog J., Glennow C. Effect of budesonide inhalation on airway obstruction at bronchial allergen provocation after varying lengths of pre-treatment. Allergy. 1984 Nov;39(8):639–640. doi: 10.1111/j.1398-9995.1984.tb01986.x. [DOI] [PubMed] [Google Scholar]